Kidney Disease Clinical Trials in Chicago

Showing 181-200 of 220 trials

Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant

NCT02490202

Safety and efficacy study of SANGUINATE on reduction of delayed graft function (DGF) in patients who will be recipients of a donation after brain death (DBD) donor kidney.

Delayed Function of Renal Transplant

Prolong Pharmaceuticals60 participantsStarted Aug 2015

Phoenix, Arizona, United States • Los Angeles, California, United States • San Diego, California, United States +17 more locations

COMPLETEDPHASE32.2 miles

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

NCT01503021

The purpose of the parent study is to assess the short-term safety and tolerability of soluble ferric pyrophosphate (SFP) in dialysate administered to a large number of representative adult chronic kidney disease patients on hemodialysis (CKD-HD). The purpose of the extension study is to assess the long-term safety and tolerability of SFP.

End Stage Renal DiseaseChronic Kidney Disease

Rockwell Medical Technologies, Inc.718 participantsStarted Nov 2011

Mobile, Alabama, United States • Northridge, California, United States • Arvada, Colorado, United States +28 more locations

Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

Kidney Disease Trials in Other Cities

Evaluation of a Website on Living Kidney Donation for Hispanics

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

Dialysis Clinical Outcomes Revisited (DCOR) Trial

Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Optimal Treatment for Kidney Disease in HIV Infected Adults

Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

Oxidative Stress in Chronic Kidney Disease: Diet and Exercise

Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

Other Conditions in Chicago